ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

42,283Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 3647

$1.18M Total Retail Price of All Prescriptions

Rank: 148 out of 3647

1,388 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 1,388 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 39,953 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 2,545 2,399 1 1
OMEPRAZOLE 1,910 1,830 2 3
LOVASTATIN 1,664 1,566 10 3 21
LEVOTHYROXINE SODIUM 1,614 1,541 4 5
GABAPENTIN 1,400 1,342 5 17
AMLODIPINE BESYLATE 1,314 1,252 6 2
ALENDRONATE SODIUM 1,069 1,005 7 23
LISINOPRIL 1,010 945 8 4
FUROSEMIDE 928 894 9 8
RANITIDINE HCL 904 866 10 29
LOSARTAN POTASSIUM 899 844 11 11
METFORMIN HCL 871 828 12 6
ALPRAZOLAM 784 767 13 31
CAPTOPRIL 755 680 10 14 193
HYDROCHLOROTHIAZIDE 730 694 15 9
METOPROLOL TARTRATE 698 654 16 7
METOPROLOL SUCCINATE 675 631 17 18
LORAZEPAM 669 652 10 18 73
CLOPIDOGREL 650 631 19 26
GLYBURIDE-METFORMIN HCL 613 539 R 20 94
FLUTICASONE PROPIONATE 607 563 21 32
TEMAZEPAM 565 541 22 47
DOXAZOSIN MESYLATE 514 489 23 57
PLAVIX 509 500 24 39
ATENOLOL 496 464 25 10
WARFARIN SODIUM 451 439 26 15
FINASTERIDE 439 433 27 66
VIAGRA 390 359 28 69
CLONIDINE HCL 383 365 29 46
IBUPROFEN 359 336 30 55
DICLOFENAC SODIUM 352 294 31 86
CARVEDILOL 349 333 32 20
BENAZEPRIL HCL 342 342 33 71
POTASSIUM CHLORIDE 333 329 34 24
NEXIUM 332 273 35 44
FENOFIBRATE 315 268 36 50
ZOLPIDEM TARTRATE 313 271 37 14
TAMSULOSIN HCL 305 300 38 28
ENALAPRIL MALEATE 259 247 39 35
SERTRALINE HCL 258 258 40 27
LACTULOSE 236 235 41 128
DONEPEZIL HCL 232 232 42 30
ALLOPURINOL 228 223 43 37
ISOSORBIDE MONONITRATE ER 217 198 44 56
DIOVAN 212 212 45 40
DIGOXIN 205 205 46 51
AZITHROMYCIN 204 174 47 34
AVODART 204 204 47 173
MECLIZINE HCL 190 181 49 85
AMLODIPINE BESYLATE-BENAZEPRIL 188 164 50 74
CLOTRIMAZOLE-BETAMETHASONE 181 159 51 84
VERAPAMIL ER 180 159 52 99
KETOCONAZOLE 178 149 53 132
NYSTATIN-TRIAMCINOLONE 176 169 54 201
AMMONIUM LACTATE 176 170 54 141
GLIPIZIDE-METFORMIN 174 171 10 56 379
GLIPIZIDE 163 162 57 41
PENTOXIFYLLINE 162 152 58 180
DILTIAZEM 24HR CD 161 161 59 155
LISINOPRIL-HYDROCHLOROTHIAZIDE 158 158 60 36
CRESTOR 152 138 61 19
NIFEDIPINE ER 151 151 62 67
ESCITALOPRAM OXALATE 147 143 63 65
NAPROXEN 141 140 64 70
LOSARTAN-HYDROCHLOROTHIAZIDE 140 140 65 48
VOLTAREN 138 125 66 102
GLIMEPIRIDE 134 134 67 45
ADVAIR DISKUS 129 125 68 52
RAMIPRIL 122 122 69 101
ATORVASTATIN CALCIUM 116 116 70 13
EASY TOUCH 115 115 71 279
PANTOPRAZOLE SODIUM 111 107 72 38
TRAMADOL HCL 106 100 73 22
TRIAMCINOLONE ACETONIDE 102 99 74 136
SINGULAIR 102 91 74 90
MELOXICAM 102 88 74 33
FELODIPINE ER 99 99 77 186
CICLOPIROX 99 94 77 176
ACTOS 98 93 79 148
FOSINOPRIL SODIUM 98 87 79 241
SPIRONOLACTONE 96 83 81 77
DIOVAN HCT 96 87 81 80
NAMENDA 94 93 83 49
LANTUS 93 93 84 59
FAMOTIDINE 92 92 85 61
LUMIGAN 92 80 85 291
VESICARE 92 92 85 209
LANSOPRAZOLE 89 89 88 116
VENTOLIN HFA 87 69 89 88
SYNTHROID 85 74 90 42
EVISTA 82 82 91 184
POTASSIUM CITRATE 81 81 92 548
AVAPRO 81 76 92 315
PROPRANOLOL HCL 80 73 94 156
OXYBUTYNIN CHLORIDE 79 79 95 107
AMIODARONE HCL 75 70 96 211
CITALOPRAM HBR 74 62 97 25
DILTIAZEM ER 74 74 97 167
GLYBURIDE 74 74 R 97 54
NOVOLOG MIX 70-30 70 70 100 261
PAROXETINE HCL 68 68 101 60
OXYBUTYNIN CHLORIDE ER 67 67 102 169
NASONEX 65 59 103 220
CLOBETASOL PROPIONATE 64 54 104 188
BENAZEPRIL-HYDROCHLOROTHIAZIDE 64 63 104 270
GALANTAMINE HBR 63 63 106 245
CIPROFLOXACIN HCL 62 59 107 53
COLCRYS 58 58 108 313
IRBESARTAN 58 49 108 232
NITROSTAT 56 53 110 206
MUPIROCIN 53 53 111 137
BENICAR 52 46 112 114
MEGESTROL ACETATE 52 52 R 112 138
TRIAMTERENE-HCTZ 52 52 112 58
PROAIR HFA 51 46 115 62
GLIPIZIDE ER 51 44 115 112
CARBAMAZEPINE 50 50 117 308
CARBIDOPA-LEVODOPA 50 50 117 127
PRANDIN 50 50 117 348
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.